Haben Sie sich noch nicht registriert? Hier kostenlos Ihr Konto eröffnen.
Passwort vergessen? Wir werden Ihnen einen Zurücksetzen Link senden
22 Dezember 2010
Merrion Pharmaceuticals Plc Signs Collaboration and Option Agreement and Warrant Agreement With Novo Nordisk
6 Dezember 2010
Merrion Pharmaceuticals Plc Signs Feasibility and Option Agreement for 3 Drugs With International ‘Top Ten’ Pharmaceutical Company
23 November 2010
Merrion Pharmaceuticals Plc Announces Commencement of Feasibility and Option Agreement With Rebel Pharmaceuticals
16 November 2010
Merrion Finalises Its Phase III Development Program for Orazol(TM) in the USA
7 Mai 2010
Merrion Pharmaceuticals is Issued a Key U.S. Patent for Orazol(TM), Their Lead Product to Treat Bone Metastases Associated With Prostate, Breast and Other Cancers
4 März 2010
Merrion Pharmaceuticals erhaelt US-Schluesselpatent
Merrion Pharmaceuticals erhält US-Schlüsselpatent
2 März 2010
Merrion Pharmaceuticals is Issued a Key United States Patent
7 Dezember 2009
Novo Nordisk Starts Phase 1 Trial With Oral Insulin Analogue — Merrion Pharmaceuticals Earns USD 2 Million Milestone Payment
20 Mai 2009
Merrion Pharmaceuticals Plc gibt erste Ergebnisse der Phase II Orazol(tm) Studie bekannt
15 Mai 2009
Merrion Pharmaceuticals Plc Announces Preliminary Results On Phase II Orazol(tm) Study
